Hybrid Event | 5.50 CE/CME Credits & MOC Points
Total Health's 2025 Best of ASCO GI Conference is an officially licensed Best of ASCO meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as a hybrid conference only with on-demand access for registered attendees.
Conference Agenda
Saturday, April 5, 2025
7:30 AM
Coffee and Exhibits
8:00 AM
Program Chair Welcome
Breakthroughs in GI Oncology
8:10 AM
Emerging Therapies: Bispecifics and ADCs
Arthur Winer, MD | Inova Schar Cancer Institute
8:30 AM
Theranostics in GI Cancers
Gabriel Fine, MD | City of Hope
8:50 AM
Breakfast and Exhibits
9:05 AM
Non-CME Breakfast provided by Incyte
Tumor-Focused Highlights
9:50 AM
Advancements in Systemic Therapy in Gastroesophageal Cancers
Reetu Mukherji, MD | MedStar Georgetown University Hospital
10:10 AM
The Evolving Role of Peritoneal-Directed Therapies in Esophagogastric Adenocarcinoma?
Steven Maron, MD, MSc | Memorial Sloan Kettering Cancer Center
10:30 AM
Risk Assessment Biomarkers for Pancreaticobiliary Cancers
Marcus Noel, MD | MedStar Georgetown University Hospital
10:50 AM
Panel Discussion: Multidisciplinary Care in Upper GI Cancers
Doris Layon Stocker, MSN, RN, OCN | Massachusetts General Hospital
Giselle Perez, PhD | Massachusetts General Hospital
Matthew Porembka, MD | UT Southwestern Medical Center
Randa Tao, MD | Mayo Clinic
11:10 AM
Lunch and Exhibits
11:25 AM
Non-CME Lunch provided by Exelixis
12:10 PM
Housekeeping and Survey
Innovations and Emerging Topics
12:20 PM
Blood-Based Testing for Colorectal Cancer: Pipeline and Practice
Bennett Caughey, MD | Massachusetts General Hospital
12:40 PM
Integrative Oncology: Mindfulness, Nutrition, and Physical Activity in GI Cancers
Christine Sardo Molmenti, PhD, MPH, RD | Northwell Health Cancer Institute
1:00 PM
The Role of the Microbiome in GI Cancer Care
Benjamin Weinberg, MD | MedStar Georgetown University Hospital
1:20 PM
Break and Exhibits
Controversies and Case Discussions
1:35 PM
Adjuvant Therapy for Resectable HCC: Pro and Con Debate
Aiwu He, MD, PhD | Columbia University Irving Medical Center
1:55 PM
Updates in Immunotherapy for MSS Colon Cancer
Timothy Cannon, MD | Inova Schar Cancer Institute
2:15 PM
Cancer Vaccines: Progress on the Promise?
Daniel Haldar, MD | MD Anderson
2:35 PM
Fireside Chat: Controversies in GI Oncology
Arturo Loiaza-Bonilla, MD, MSEd, FACP | St. Luke’s University Health Network
Raymond Wadlow, MD | Inova Schar Cancer Institute
2:55 PM
Break and Exhibits
Future Directions and Wrap-Up
3:10 PM
Advances in Systemic Therapies for Pancreaticobiliary Cancers
Michael Pishvaian, MD, PhD | Sibley Memorial Hospital
3:30 PM
Expanding the Limits of Endoscopic Therapy for Early GI Cancers
Saowanee Ngamruengphong, MD | Johns Hopkins University
3:50 PM
Geriatric Assessment and Management Improves Treatment Decisions and Patient Centered Care in GI Malignancies
Tracy Webb, PA | Inova Schar Cancer Institute
4:10 PM
Adjourn
Agenda Subject To Change. All times are EST.
-
Review and analyze the latest therapeutic advances for the treatment and management of GI cancer.
Apply new data and therapeutic advances into guideline-driven treatment strategies to improve the care of patients with GI cancers, neuroendocrine tumors, and hepatocellular cancers
Identify subpopulations of patients with gastrointestinal cancers most likely to benefit from a specific treatment plan based on prognostic or predictive markers
Evaluate the role of ctDNA and MRD in GI cancers
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 5.50 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 5.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 5.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources